Coronado Research is a consultancy-led professional services organization operating in the clinical development sector. The company aims to assist pharmaceutical and biotechnology firms in optimizing their drug development programs by leveraging data and technology, effectively bridging the gap from regulatory strategy to market access. Recognizing the limitations of the traditional "blockbuster" model in bringing new treatments to market, Coronado Research emphasizes the need to reevaluate clinical strategies and utilize the growing volumes of available data to expedite the transition from laboratory research to patient care. By integrating subject matter experts with data scientists, the company seeks to harness advanced technologies, including artificial intelligence (AI) and machine learning (ML), to align stakeholders throughout the development process.
Coronado Research's strategic focus centers on optimizing clinical development processes through the innovative use of data and technology. The company specializes in areas such as regulatory strategy, advanced analytics, market access, health economics, and technology. By treating data as a unifying element, Coronado Research aims to align various stakeholders across the development continuum, ensuring that treatments are developed with a clear understanding of market needs and patient outcomes.
The company was established with investment from Conditor Capital, a firm with a portfolio already positioned in the pre-clinical space. The investment underscores Conditor Capital's confidence in Coronado Research's vision and its potential to deliver value to clients by optimizing clinical development through data utilization.
Coronado Research's technological platform is distinguished by its integration of AI and ML to enhance clinical development processes. By leveraging these advanced technologies, the company aims to accelerate drug development timelines and ensure that new treatments are more closely aligned with market demands. This approach involves treating data as a common thread to connect stakeholders across the development process, thereby facilitating more informed decision-making and efficient resource allocation.
The leadership team at Coronado Research comprises experienced professionals with extensive backgrounds in clinical development and data science:
- Andrew MacGarvey, Founder and CEO, brings a deep understanding of data utilization in clinical development and a strong commitment to delivering value to clients.
- Dr. Nicholas Edwards, Chair, has significant experience in life sciences consulting and scaling professional services businesses, notably serving as the global lead for Accenture's R&D practice and as a founder of Kinapse.
- Jo Marshall, Executive Vice President of Data Services and Advanced Analytics, brings a wealth of experience in data services and analytics, contributing to the company's focus on leveraging data for clinical development.
- Dr. Jennifer Bradford, Vice President and Head of Data Science, has a diverse background in data science, enhancing the company's capabilities in utilizing advanced data methodologies.
The company has recently announced significant appointments to strengthen its leadership team:
- Dr. Nicholas Edwards was appointed as Chair, bringing his extensive experience in life sciences consulting and professional services.
- Jo Marshall joined as Executive Vice President of Data Services and Advanced Analytics, enhancing the company's focus on data-driven strategies.
- Dr. Jennifer Bradford was appointed as Vice President and Head of Data Science, contributing her expertise to the company's data science initiatives.
Coronado Research operates in a competitive landscape that includes other consultancy-led organizations specializing in clinical development optimization through data and technology. The market is characterized by a growing emphasis on integrating advanced analytics and AI to streamline drug development processes. Key competitors focus on similar areas, offering services that encompass regulatory strategy, market access, and the application of data science to clinical development.
The company has established strategic collaborations to enhance its market position and innovation capacity. Notably, the partnership with Conditor Capital provides not only financial backing but also valuable sector knowledge and industry networks, supporting Coronado Research's mission to optimize clinical development through data and technology.
Coronado Research's strategic roadmap includes expanding its service offerings in regulatory strategy, advanced analytics, market access, health economics, and technology. By leveraging its strengths in data utilization and technological innovation, the company aims to further accelerate drug development timelines and ensure that new treatments are better aligned with market needs. Future directions involve deepening collaborations with pharmaceutical and biotechnology companies to support their clinical development programs through the application of AI and ML technologies.
For more information, visit Coronado Research's official website.
